SCHEMBL14422263

SCHEMBL14422263

O=C(Nc1ccc(Br)cc1)c1csc(Nc2ncccc2Cl)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
KDM1A O60341 3/20 0.50
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
AMY1A P0DUB6 3/20 0.45
GRM4 Q14833 2/20 0.45
CLK1 P49759 2/20 0.44
CLK4 Q9HAZ1 2/20 0.44
DYRK3 O43781 1/20 0.42
CLK2 P49760 1/20 0.42
DYRK1A Q13627 1/20 0.42
DYRK2 Q92630 1/20 0.42
DYRK1B Q9Y463 1/20 0.42
MAPT P10636 4/20 0.42
LMNA P02545 2/20 0.42
NPY1R P25929 1/20 0.42
NPY2R P49146 1/20 0.42
ATM Q13315 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14422194 0.87 NPC1 (0.50) MEN1KMT2AKDM1ANPC1RAB9A
SCHEMBL14422262 0.86 MAPK1 (0.55) MEN1KMT2AGRM4MAPTLMNA
SCHEMBL14422241 0.85 KDM1A (0.55) MEN1KMT2AKDM1ANPC1RAB9A
SCHEMBL14422234 0.84 KMT2A (0.52) MEN1KMT2AKDM1ANPC1RAB9A
SCHEMBL14422247 0.83 RAB9A (0.64) MEN1KMT2AKDM1ANPC1RAB9A
SCHEMBL14422235 0.81 KMT2A (0.56) MEN1KMT2AKDM1ANPC1RAB9A
SCHEMBL5215470 0.81 RAB9A (0.50) MEN1KMT2AKDM1ANPC1RAB9A
SCHEMBL14422251 0.78 KDM1A (0.56) MEN1KMT2AKDM1ANPC1RAB9A
SCHEMBL14422256 0.78 KDM1A (0.47) MEN1KMT2AKDM1ANPC1RAB9A
SCHEMBL14422240 0.75 NPC1 (0.52) MEN1KMT2AKDM1ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7265138-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2007-09-04 US disclosed
US-7265138-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2007-09-04 US disclosed
EP-1818333-A1 Vanilloid receptor ligands and their use in treatments Amgen Inc. (US) 2007-08-15 EP disclosed